Alteration in brain-derived neurotrophic factor (BDNF) after treatment of mice with herbal mixture containing Euphoria longana, Houttuynia cordata and Dioscorea japonica

DARU, Journal of Pharmaceutical Sciences

Volumn 22, Issue 1, 2014, Pages

  Jeon, Songhee ^a   Lee, Chia Hung ^b   Liu, Quan Feng ^b   Kim, Geun Woo ^c   Koo, Byung Soo ^b   Pak, Sok Cheon ^d  

^a Dongguk University   (South Korea)

^b Dongguk University   (South Korea)

^c Dongguk University Bundang Oriental Hospital   (South Korea)

^d CHARLES STURT UNIVERSITY   (Australia)

Author keywords

BDNF; Depression; Dioscorea japonica; Euphoria longana; Houttuynia cordata; Memory; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HERBACEOUS AGENT; PROTEIN KINASE B; ANTIDEPRESSANT AGENT; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; CREB1 PROTEIN, HUMAN; NEUROPROTECTIVE AGENT; PLANT EXTRACT, HOUTTUYNIA CORDATA;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CELL VIABILITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIMOCARPUS LONGAN; DIOSCOREA JAPONICA; DRUG EFFECT; DRUG MIXTURE; EXPERIMENTAL BEHAVIORAL TEST; HIPPOCAMPUS; HOUTTUYNIA CORDATA; HUMAN; HUMAN CELL; IMMOBILITY; IMMUNOBLOTTING; IN VITRO STUDY; LOW DRUG DOSE; MALE; MOUSE; NEUROBLASTOMA CELL LINE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PLANT SEED; PROTEIN EXPRESSION; SH SY5Y CELL LINE; SPATIAL MEMORY TEST; STRESS; TAIL SUSPENSION TEST; YAM; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DEPRESSION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HOUTTUYNIA; IMMOBILIZATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MEDICINAL PLANT; MEMORY; MEMORY DISORDERS; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PHOSPHORYLATION; PHYTOTHERAPY; PSYCHOLOGY; SAPINDACEAE; TUMOR CELL LINE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSION; DIOSCOREA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HOUTTUYNIA; HUMANS; IMMOBILIZATION; MALE; MEMORY; MEMORY DISORDERS; MICE, INBRED ICR; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PHYTOTHERAPY; PLANTS, MEDICINAL; PROTO-ONCOGENE PROTEINS C-AKT; SAPINDACEAE; STRESS, PSYCHOLOGICAL;

EID: 84988654892     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/s40199-014-0077-2     Document Type: Article

References (37)

1. Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Degenhardt L, Whiteford HA: The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD2010. Epidemiol Psychiatr Sci 2014, 23:1-11.
2. Bryant K, Wicks MN, Willis N: Recruitment of older African American males for depression research: lessons learned. Arch Psychiatr Nurs 2014, 28:17-20.
3. Hung CJ, Wu CC, Chen WY, Chang CY, Kuan YH, Pan HC, Liao SL, Chen CJ: Depression-like effect of prenatal buprenorphine exposure in rats. PLoS One 2013, 8:e82262.
4. Davies AM: The role of neurotrophins in the developing nervous system. Neurobiol 1994, 25:1334-1348.
5. Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
6. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003, 54:70-75.
7. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME: Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20:709-726.
8. Crawford AA, Lewis S, Nutt D, Peters TJ, Cowen P, O'Donovan MC, Wiles N, Lewis G: Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals. Psychopharmacol (Berl) 2014, 231:2921-2931.
9. Ferguson JM: SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 2001, 3:22-27.
10. Rangkadilok N, Worasuttayangkurn L, Bennett RN, Satayavivad J: Identification and quantification of polyphenolic compounds in Longan (Euphoria longana Lam.) fruit. J Agric Food Chem 2005, 53:1387-1392.
11. Panyathep A, Chewonarin T, Taneyhill K, Vinitketkumnuen U, Surh YJ: Inhibitory effects of dried longan (Euphoria longana Lam.) seed extract on invasion and matrix metalloproteinases of colon cancer cells. J Agric Food Chem 2013, 61:3631-3641.
12. Kumar M, Prasad SK, Krishnamurthy S, Hemalatha S: Antihyperglycemic activity of Houttuynia cordata Thunb. in streptozotocin-induced diabetic rats. Adv Pharmacol Sci 2014, 2014:809438.
13. Kim SK, Ryu SY, No J, Choi SU, Kim YS: Cytotoxic alkaloids from Houttuynia cordata. Arch Pharm Res 2001, 24:518-521.
14. Cho EJ, Yokozawa T, Rhyu DY, Kim SC, Shibahara N, Park JC: Study on the inhibitory effects of Korean medicinal plants and their main compounds on the 1,1-diphenyl-2-picrylhydrazyl radical. Phytomedicine 2003, 10:544-551.
15. Wu JN: Chinese Materia Medica. New York: Oxford University Press; 2005:264.
16. Kim KH, Choi SU, Choi SZ, Son MW, Lee KR: Withanolides from the rhizomes of Dioscorea japonica and their cytotoxicity. J Agric Food Chem 2011, 59:6980-6984.
17. Saleem AM, Taufik Hidayat M, Mat Jais AM, Fakurazi S, Moklas M, Sulaiman MR, Amom Z: Antidepressant-like effect of aqueous extract of Channa striatus fillet in mice models of depression. Eur Rev Med Pharmacol Sci 2011, 15:795-802.
18. Dwivedi Y: Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat 2009, 5:433-449.
19. Sala M, Perez J, Soloff P, Ucelli di Nemi S, Caverzasi E, Soares JC, Brambilla P: Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol 2004, 14:393-405.
20. Campbell S, Marriott M, Nahmias C, MacQueen GM: Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004, 161:598-607.
21. Frodl T, Schaub A, Banac S, Charypar M, Jäger M, Kümmler P, Bottlender R, Zetzsche T, Born C, Leinsinger G, Reiser M, Möller HJ, Meisenzahl EM: Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 2006, 31:316-323.
22. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002, 109:143-148.
23. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S: Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005, 255:381-386.
24. Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, Ueda N, Nakamura J: Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1034-1037.
25. Lee HY, Kim YK: Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008, 57:194-199.
26. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
27. Huang TL, Lee CT, Liu YL: Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 2008, 42:521-525.
28. Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J: Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res 2011, 221:166-171.
29. Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995, 15:1768-1777.
30. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Toné S, Senba E: Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 1997, 28:103-110.
31. Rasmusson AM, Shi L, Duman R: Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 2002, 27:133-142.
32. Roceri M, Hendriks W, Racagni G, Ellenbroek BA, Riva MA: Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 2002, 7:609-616.
33. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, Alagappan A, Bah MJ, Dawood MY, Shah JD, Mark B, Kendall N, Smith MA, Saviolakis GA, Meyerhoff JL: Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res 2004, 1025:10-20.
34. Huang Y, Shi X, Xu H, Yang H, Chen T, Chen S, Chen X: Chronic unpredictable stress before pregnancy reduce the expression of brain-derived neurotrophic factor and N-methyl-D-aspartate receptor in hippocampus of offspring rats associated with impairment of memory. Neurochem Res 2010, 35:1038-1049.
35. Marmigère F, Givalois L, Rage F, Arancibia S, Tapia-Arancibia L: Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 2003, 13:646-655.
36. Wolf OT: HPA axis and memory. Best Pract Res Clin Endocrinol Metab 2003, 17:287-299.
37. Kitraki E, Kremmyda O, Youlatos D, Alexis M, Kittas C: Spatial performance and corticosteroid receptor status in the 21-day restraint stress paradigm. Ann N Y Acad Sci 2004, 1018:323-327.